GeminiBio launches human serum AB product for global cell therapy market

WEST SACRAMENTO, Calif., Feb. 26, 2024 /PRNewswire/ — Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of cell culture reagents and process liquids, a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, today…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks